6 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
Patient risk stratification ... algorithm for the ... treatment of cancer-associated ... mass index; VTE = venous ... #Management #Hematology
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Longterm Venous ... Thromboembolism Treatment ... Algorithm Treat ... #Algorithm #management ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Treatment algorithms ... patients with no CV risk ... (if history of venous ... #hematology #diagnosis ... #management #hematology
A quick infographic on various pearls about atopic dermatitis, a disease with an increasing burden on
about possible risk ... pimecrolimus and cancers ... hydroxyvitamin D levels and severity ... of "wet wraps" versus ... Arch Dis Child.
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment ... algorithm 2018. ... Myelodysplastic syndromes ... #algorithm #hematology
Hemophagocytic Lymphohistiocytosis (HLH)

High mortality without prompt recognition and management. HLH is a critical diagnostic consideration in
it is often a cancer ... Diagnostic Criteria ... of 8 HLH-2004 criteria ... molecular diagnosis: HScore ... Diagnosis #Management #Hematology